Treating adhesive selection as a trivial exercise can result in manufacturing issues, device malfunctions and potential patient harm.
Validation is an obstacle to implementing technology. A streamlined approach is necessary.
With the heightened supplier scrutiny, it’s time to reevaluate your supplier quality program.
Before accepting money, the following is a guide to your due diligence process.
The device will no longer be available after December 31, 2018.
Technology isn’t the only driver in this change; the sociological factor plays a role as well.
When it comes to adverse event reporting, the FDA does not grant exemptions.
Many considerations should not be overlooked.
Digital transformation, artificial intelligence and start-up technologies are some of the topics that will be discussed at the event in November.
New technologies are enabling more effective product development, better clinician training and detailed surgical planning.